Literature DB >> 30233895

Lung adenocarcinoma patient progression with gastrointestinal metastasis response to subsequent tyrosine kinase inhibitors (TKIs) from re-biopsy of new occurring driver gene mutation.

Chunhua Zhou1, Binjie Yan1, Liang Zeng1, Yi Xiong1, Li Liu1, Nong Yang1, Yongchang Zhang1.   

Abstract

Entities:  

Year:  2018        PMID： 30233895      PMCID： PMC6129912          DOI： 10.21037/jtd.2018.07.97

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  18 in total

Review 1.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

2.  Crizotinib in ROS1-rearranged non-small-cell lung cancer.

Authors:  Alice T Shaw; Sai-Hong I Ou; Yung-Jue Bang; D Ross Camidge; Benjamin J Solomon; Ravi Salgia; Gregory J Riely; Marileila Varella-Garcia; Geoffrey I Shapiro; Daniel B Costa; Robert C Doebele; Long Phi Le; Zongli Zheng; Weiwei Tan; Patricia Stephenson; S Martin Shreeve; Lesley M Tye; James G Christensen; Keith D Wilner; Jeffrey W Clark; A John Iafrate
Journal:  N Engl J Med       Date:  2014-09-27       Impact factor: 91.245

Review 3.  Liquid biopsies come of age: towards implementation of circulating tumour DNA.

Authors:  Jonathan C M Wan; Charles Massie; Javier Garcia-Corbacho; Florent Mouliere; James D Brenton; Carlos Caldas; Simon Pacey; Richard Baird; Nitzan Rosenfeld
Journal:  Nat Rev Cancer       Date:  2017-02-24       Impact factor: 60.716

4.  Real-world Efficacy and Safety of Nivolumab for Advanced Non-Small-cell Lung Cancer: A Retrospective Multicenter Analysis.

Authors:  Keigo Kobayashi; Ichiro Nakachi; Katsuhiko Naoki; Ryosuke Satomi; Morio Nakamura; Takashi Inoue; Hiroki Tateno; Fumio Sakamaki; Koichi Sayama; Takeshi Terashima; Hidefumi Koh; Takayuki Abe; Makoto Nishino; Daisuke Arai; Hiroyuki Yasuda; Ichiro Kawada; Kenzo Soejima; Tomoko Betsuyaku
Journal:  Clin Lung Cancer       Date:  2018-01-05       Impact factor: 4.785

5.  Gastrointestinal metastases from primary lung cancer.

Authors:  Akihiro Yoshimoto; Kazuo Kasahara; Atsuhiro Kawashima
Journal:  Eur J Cancer       Date:  2006-10-31       Impact factor: 9.162

Review 6.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

7.  Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers.

Authors:  Ryoichi Onozato; Takayuki Kosaka; Hiroyuki Kuwano; Yoshitaka Sekido; Yasushi Yatabe; Tetsuya Mitsudomi
Journal:  J Thorac Oncol       Date:  2009-01       Impact factor: 15.609

8.  Primary lung cancer presenting with gastrointestinal tract involvement: clinicopathologic and immunohistochemical features in a series of 18 consecutive cases.

Authors:  Giulio Rossi; Alessandro Marchioni; Elena Romagnani; Federica Bertolini; Lucia Longo; Alberto Cavazza; Fausto Barbieri
Journal:  J Thorac Oncol       Date:  2007-02       Impact factor: 15.609

9.  EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291.

Authors:  Kenneth S Thress; Roz Brant; T Hedley Carr; Simon Dearden; Suzanne Jenkins; Helen Brown; Tracey Hammett; Mireille Cantarini; J Carl Barrett
Journal:  Lung Cancer       Date:  2015-10-09       Impact factor: 5.705

10.  Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.

Authors:  Jacob J Chabon; Andrew D Simmons; Alexander F Lovejoy; Mohammad S Esfahani; Aaron M Newman; Henry J Haringsma; David M Kurtz; Henning Stehr; Florian Scherer; Chris A Karlovich; Thomas C Harding; Kathleen A Durkin; Gregory A Otterson; W Thomas Purcell; D Ross Camidge; Jonathan W Goldman; Lecia V Sequist; Zofia Piotrowska; Heather A Wakelee; Joel W Neal; Ash A Alizadeh; Maximilian Diehn
Journal:  Nat Commun       Date:  2016-06-10       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.